L&K Bio Obtains US FDA Approval for Spinal Implant Products
[Asia Economy Reporter Minji Lee] L&K Bio announced on the 29th that it has obtained the U.S. Food and Drug Administration (FDA) import approval for spinal implant products.
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Smoke from Suspected Portable Battery on Seoul Subway Line 2 at Sillim Station... All Passengers Evacuated
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
The company stated, "The newly approved products include additional sterilized products, which are the same products provided by the manufacturer with sterilization treatment, and the SAI Screw product."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
